HLVX down 88% HilleVax Inc.'s stock cratered 87% on Monday, after the biotech said it would discontinue the development of a vaccine against norovirus for infants after a trial missed its main goals.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.